MCM
SRGA

Matarin Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Matarin Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-460
Closed -$62.8K – 323
2017
Q3 		$62.8K Hold
460
– – 0.01% 290
2017
Q2 		$80.8K Buy
+460
New +$65.4K 0.01% 274

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Matarin Capital Management's SRGA Position: Q4 2017 in Review

Matarin Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2017, closing a stake of 460 shares — an estimated $62.8K sold.

Matarin Capital Management first reported a position in SRGA in Q2 2017 and held it in 2 quarters. The position peaked at $80.8K in Q2 2017. 109 funds tracked by Wall St. Rank hold SRGA as of Q4 2017.

  • Matarin Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Matarin Capital Management sold 460 Surgalign Holdings, Inc. Common Stock shares in Q4 2017, an estimated $62.8K.
  • Matarin Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Matarin Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $80.8K in Q2 2017.
  • 109 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2017.

Based on Matarin Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.